The projected amount of Smith & Nephew’s equity is 57 percent higher than its average market value in the past 20 days, which makes it among the industry’s most expensive, according to the report. Johnson & Johnson and General Electric are the only companies that have completed deals at prices that high in the past ten years.
Keith Wirtz, the company’s chief investment officer, says any other company seeking to acquire Smith & Nephew will have to meet the company’s value.
Read the Bloomberg Businessweek report on Smith & Nephew.
Read other coverage on Smith & Nephew:
– Smith & Nephew Adds 100 Employees
– Smith & Nephew CEO Speaks About Orthopedic Device Environment
– Smith & Nephew Denies Discussion of Mergers or Takeovers
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
